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Background: Patients with prosthetic heart valves have an increased risk of throm-
boembolic events, and transcranial Doppler sonography reveals microembolic sig-
nals. Whereas microembolic signals were initially assumed to be of particulate
matter, recent studies suggest that they are partially gaseous in origin. If this is true,
alteration of environmental pressure should change microembolic signal counts. We
undertook this study to evaluate the influence of hyperbaric exposure on microem-
bolic signal counts in persons with prosthetic heart valves. 
Methods and Results: Microembolic signal counts were monitored by transcranial
Doppler sonography of both middle cerebral arteries under normobaria (normobaria
1), 2 subsequent periods of hyperbaria (2.5 and 1.75 bar), and a second period of nor-
mobaria (normobaria 2) in 15 patients with prosthetic heart valves. Each monitoring
period lasted 30 minutes. Compression and decompression rates were 0.1 bar/min.
Microembolic signal counts increased from 20 (12-78) at normobaria 1 to 79 (30-165)
at 2.5 bar (P < .01 vs normobaria 1 and 2), decreased to 44 (18-128) at 1.75 bar (P <
.01 vs normobaria 1 and 2.5 bar; P < .001 vs normobaria 2), and returned to 20 (8-96)
at normobaria 2 (values are medians and 95% confidence intervals).
Conclusions: Our results strongly suggest that gaseous bubbles are underlying
material for part of the microembolic signals detected in patients with prosthetic
heart valves.
The implantation of prosthetic heart valves represents an importantdevelopment in cardiac surgery because the valves improve thehemodynamic function of the heart. Unfortunately, prosthetic heartvalves are associated with thromboembolic events, which occurdespite adequate anticoagulation in 0.8% to 5.1% per patient-year.1-5The risk is cumulative over time, involves the cerebral circulation in
more than 85% of cases, and leads to a permanent neurologic deficit in 50% and to
death in 10%.2,6,7
Monitoring for microembolic signals (MES) by means of transcranial Doppler
sonography is a validated technique for detection of embolic material in the
insonated sample volume.8,9 To date, MES detection has been described in several
stroke-prone patient groups, including patients with artificial heart valves.10-13 The
clinical relevance of MES in the latter group remains a matter of debate. At the same
time, unequivocal evidence concerning the underlying embolic material is still lack-
ing. Recently reported significant changes in MES counts during inhalation of
100% oxygen suggest that at least part of MES are caused by nitrogen bubbles.14 If
this were true, hyperbaria would be expected to influence the number of MES. Up
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to now, 3 patients with prosthetic heart valves have been
examined under hyperbaric conditions with conflicting
results, because the number of MES increased in 2 patients
but remained unchanged in the other.15,16
The purpose of the present hyperbaric chamber study
was to investigate MES counts in patients with prosthetic
heart valves during exposure to 2 different levels of hyper-
baria (2.5 and 1.75 bar) and to compare them with MES
counts measured at normobaria.
Patients and Methods
Patients
Thirty-five patients with prosthetic heart valves and no history of
thromboembolic disease were recruited from the Department of
Cardiothoracic Surgery and the Division of Cardiology, Department
of Internal Medicine, University of Zurich, Switzerland. During the
study the anticoagulation levels were within the accepted norms for
the prostheses used. Twenty patients were included in the study,
because 15 patients were excluded on the basis of the criteria men-
tioned below. All exclusions resulted from scuba diving criteria,
whereas no patient was excluded because of ultrasonic criteria.
Inclusion criteria were the presence of artificial heart valves, at
least one temporal acoustic window providing adequate spectral
Doppler signals from the middle cerebral artery (MCA), and no
ultrasonographic evidence of stenosis or occlusion of extracranial
and intracranial cerebral arteries.
Internationally accepted exclusion criteria for scuba diving were
applied to avoid adverse effects resulting from hyperbaria. These cri-
teria were history of overpressure accident in previous diving, his-
tory of nervous system disease including seizure disorder,
psychiatric disease including substance and drug abuse, coryza,
bronchitis, inability to equalize pressure in the middle ear by autoin-
flation, perforation of the tympanic membrane, middle ear surgery
with placement of a prosthesis in the conduction chain, symptomatic
coronary artery disease, bullous lung disease, significant obstructive
pulmonary disease, history of spontaneous pneumothorax, abdomi-
nal hernia, and pregnancy.17
Stenosis or occlusion of cerebral arteries may cause MES.
Therefore, all patients were evaluated by extracranial and transcra-
nial color duplex sonography, and the presence of cerebral artery
stenosis or occlusion was another exclusion criterion.
Written informed consent was obtained from all patients, and our
study protocol was reviewed and approved by the Ethical Committee
of the University Hospital in Zurich.
Ultrasonic Examinations
The common, internal, and external carotid arteries and the sub-
clavian and vertebral arteries were investigated with the use of a
color duplex scanner (Acuson Sequoia, Mountain View, Calif)
equipped with a linear 4- to 8-MHz probe. Transorbital insonation
of the ophthalmic arteries and the carotid siphon was performed by
means of a transcranial Doppler device (TC2-64B, EME, Überlin-
gen, Germany) equipped with a 2-MHz probe. Transtemporal and
transoccipital insonation of the anterior, middle, and posterior
cerebral arteries and the intracranial vertebral and basilar arteries
was done with a 2.0- to 3.5-MHz sector probe attached to the same
color duplex scanner used for extracranial insonation. Examination
and assessment of cerebral artery stenosis and occlusion were per-
formed as reported previously.18-21
Hyperbaric Chamber Study
The hyperbaric chamber of the Division of Pneumology,
Department of Internal Medicine, University of Zurich, was used
for this study. Because of place restriction, each exposure to
hyperbaria was performed with a maximum of 2 patients under
the surveillance of 1 examiner in the chamber as well as 2 mem-
bers of the staff of the hyperbaric chamber who were performing
compression and decompression. The patients were examined in
the supine position. The MCA was insonated bilaterally through
the temporal acoustic window, and both 2-MHz transducers were
fixed on the skull with an elastic band to minimize movement arti-
facts. Two pulsed-wave Doppler machines (Multi-Dop X; DWL,
Sipplingen, Germany) were located outside the hyperbaric cham-
ber. The ultrasound devices were connected to the transducers by
a cable, which penetrated the wall of the chamber through a pres-
sure-stable valve. Persons within and outside the chamber were in
contact by intercom.
The number of MES and the heart rate (HR) were counted in
both MCAs under normobaria (normobaria 1) for 30 minutes.
Subsequently, both patients and the investigator were compressed
to 2.5 bar, which corresponds to a sea water depth of 15 m. The
rate of compression was 0.1 bar/min. MES and HR were registered
in both MCAs for 30 minutes under stable hyperbaria of 2.5 bar.
Thereafter, the patients and the investigator were decompressed at
a rate of 0.1 bar/min to 1.75 bar, which corresponds to a sea water
depth of 7.5 m. Under stable hyperbaria of 1.75 bar, MES and HR
were registered in both MCAs for 30 minutes. Final decompres-
sion to normobaria (normobaria 2) was done at a rate of 0.1
bar/min, and MES and HR were registered in both MCAs for 30
minutes under normobaria.
Microembolic Signal Detection
The MCA was insonated at 2 spatially separated depths (distal
sample volume at 46 to 52 mm, proximal sample volume at 52 to
57 mm). The distance between the 2 sample volumes was set at 5
mm. A 64-point fast Fourier transformation (FFT) was used with
an FFT length of 2 ms and an FFT overlap of 60%. Settings of the
Doppler machine were as follows: power 110 mW, sample volume
5 to 8 mm, low-pass filter 80 kHz, high-pass filter 100 Hz, and
sweep 5 seconds. These settings were used throughout the study.
MES were detected on the basis of the following criteria: (1)
characteristic sound, (2) unidirectionality within the flow signature
of the vessel monitored, (3) intensity increase at least 6 dB above
background, and (4) random appearance in the cardiac cycle
according to a recent consensus statement.22 Two human observers
were present during all monitoring sessions. Additionally, all ultra-
sound data were harvested in an 8-channel DAT recorder (TAS-
CAM DA 88; Tascam Corp, Los Angeles, Calif) for later
re-evaluation. This was performed by assigning all tapes to another
experienced observer, blinded to the identity of the patient and the
period of examination. Both examiners were asked to note the
exact position of each MES, based on the time display of the DAT
recorder. Only signals identified as MES by both observers were
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further evaluated. MES counts represent the sum of both MCAs.
Differences between the 2 sides were not further evaluated.
Statistical Analysis
Normally distributed data were expressed as mean ± standard devi-
ation; nonnormally distributed data were expressed as median and
95% confidence intervals. MES and HR measurements obtained at
both normobaric and hyperbaric periods were compared with each
other by nonparametric analysis of variance by means of the
Friedman test and the Wilcoxon signed rank test.
Interobserver agreement was evaluated by means of the Cohen
κ statistic. Values derived from this evaluation ranged between –1
(complete disagreement) and 1 (complete agreement), with a value
of 0 reflecting a lacking relation between the evaluations of the 2
observers. Acceptable to good agreement is indicated by values
between 0.4 and 0.75; values greater than 0.75 indicate an excel-
lent agreement.23
Results
Adverse Events and Dropouts
Three patients had ear pain during the first meters of hyper-
baria. Compression was stopped immediately, and the patients
were decompressed slowly. Ear pain disappeared completely
within 15 to 320 minutes. Two patients withdrew from the
study. Thus, 15 patients completed the study protocol. These
were 2 women and 13 men, aged 52 ± 12 years (range 25-75
years). They had Carbomedics (Sulzer Carbomedics, Inc,
Austin, Tex; n = 13) and St Jude Medical (St Jude Medical,
Inc, St Paul, Minn; n = 4) valves in the aortic (n = 9), mitral (n
= 4), or both mitral and aortic positions (n = 2).
Microembolic Signal Counts (Figure 1 and Table 1)
During normobaria 1 the number of detected MES was 20
(12-78). During hyperbaria of 2.5 bar the number of MES
increased to 79 (30-165; P < .01 vs normobaria 1). The
number decreased to 44 (18-128) during hyperbaria of 1.75
bar (P < .01 vs normobaria 1 and hyperbaria of 2.5 bar).
MES counts decreased during normobaria 2 to 20 (8-96)
and were lower than the counts recorded during hyperbaria
of 2.5 bar (P < .01) and 1.75 bar (P < .001) (Friedman test:
P < .001; values are medians [95% confidence intervals]).
Heart Rate
HR was 72 beats/min (67-80 beats/min) at normobaria 1,
remained stable at 2.5 bar (70 [64-78]), decreased at 1.75
bar (68 [61-73]; P < .01 vs normobaria 1), and increased to
71 beats/min (66-77 beats/min) at normobaria 2 (P < .05 vs
hyperbaria of 1.75 bar) (Friedman test: P < .01; values are
medians [95% confidence intervals]).
Interobserver Agreement
A total of 4562 MES were detected by at least 1 observer
(first observer 4420, second observer 4437). Both observers
unanimously identified 4295 signals as MES. A total of 105
signals (2.3%) were identified by 1 observer as MES and
overlooked by the other one, and 152 signals (3.3%) were
identified as MES by 1 observer and as artifacts by the
other. The acquired κ value indicated excellent observer
agreement (κ = 0.97).
Discussion
Although MES in patients with prosthetic valves were
already described in 1990,24 their underlying embolic mate-
rial remained a matter of continuous debate. The lack of
influence of the intensity of oral anticoagulation on MES
counts,25 the lack of correlation between MES counts and
D-dimers, thrombin-antithrombin complex, and antithrom-
bin III levels,26 and the insignificant changes in MES counts
despite the administration of aspirin or heparin27 essentially
argued against full blood clots or activated platelets as
underlying embolic material. The exponential decrease in
MES counts during inhalation of 100% oxygen, which cor-
responded with the exponential decline in blood nitrogen
concentration, suggested nitrogen gas bubbles as underlying
embolic material.14 The present study adds further weight to
this hypothesis: exposure to hyperbaria resulted in a signif-
icant increase in MES counts, which essentially returned to
baseline values under normobaric conditions. This pattern
corresponds to concordant changes in the partial pressure of
Figure 1. MES counts during normobaria, 2 subsequent levels of
hyperbaria (2.5 and 1.75 bar), and a second period of normobaria
in 15 patients with prosthetic heart valves. MES counts are
expressed as medians and 95% confidence intervals and are
compared by means of the Wilcoxon signed rank test (Friedman
test for all 4 measurement periods, P < .0001).
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nitrogen, which have been extensively described in diving
literature.17,28
An increasing HR during exposure to hyperbaria might
be another explanation of the raised MES counts observed
in this study. At hyperbaria, however, HR either remained
unchanged or decreased compared with normobaric values.
These findings indicate that HR did not increase MES
counts at hyperbaria.
Generation of cavitation bubbles through mechanical valves
is a common occurrence in mock circulation flow loops.29-31
Still, these bubbles are supposed to implode within millisec-
onds32,33 and should thus be unable to enter the cerebral circu-
lation. We hypothesize that some cavitation bubbles could be
energetically more stable and thus have a longer life span than
previously assumed. In particular, cavitation bubbles of bigger
diameter possess a higher stability and a longer life span, which
could potentially allow them to enter the systemic circulation.31
Observations on cavitation bubbles were almost solely per-
formed under in vitro conditions, with water or normal saline
solution as the circulating fluid, so that the influence of poten-
tial interactions between blood contents (particularly serum
proteins) and cavitation bubbles could not be examined.
Bubbles could indeed be detected several centimeters down-
stream from the prosthetic valve with an ultrasound probe in a
recently published study, where porcine blood was used as cir-
culating fluid in the mock circulatory loop,34 indicating a life
span in the order of seconds. Therefore, the assumption that the
underlying material of MES in patients with prosthetic heart
valves could consist of cavitation bubbles appears more proba-
ble than initially assumed.
The number of cavitation bubbles decreases with rising
static pressure.35 Hence, hyperbaria is expected to suppress
cavitation and decrease the number of MES. Consequently,
another mechanism such as an augmented concentration of
blood gases may better explain the increased MES counts
observed in this study. According to Henry’s law, the
amount of gas that will dissolve in a liquid (eg, blood) at a
given temperature (eg, body temperature) is almost directly
proportional to the partial pressure of that gas.35 At hyper-
baria of 1.75 and 2.5 bar, the partial pressures and arterial
concentrations of carbon dioxide and water vapor will
remain stable,35 suggesting that these gases are not the
cause of increased MES. When alveolar partial pressure of
oxygen rises to values of about 400 mm Hg, which occurs
at 2.5 bar, the maximum oxygen saturation of hemoglobin
can never increase above 100%.35 Thus, the saturation of
hemoglobin would increase by only 3% because 97% of the
hemoglobin is already combined with oxygen.35
Furthermore, only a small amount of oxygen will dissolve
in the blood.35 These findings suggest that raised arterial
partial pressure and concentration of oxygen is an unlikely
cause of increased MES counts found at hyperbaria. At
atmospheric pressures of 1.75 and 2.5 bar, the partial pres-
sure and concentration of nitrogen will increase.17,28,35
Therefore, it is assumed that hyperbaria increases the
amount of dissolved nitrogen and thus cavitation bubbles,
leading to an increased number of MES. This process seems
to be only partially counteracted by the reduced number of
cavitation bubbles formed during hyperbaria.
Obviously, the results of the present study cannot be
extrapolated to all MES detected in patients with prosthetic
heart valves. It appears probable that a portion of these sig-
nals is caused by formed embolic material. Currently, no
method is able to distinguish between gaseous and formed
TABLE 1. MES counts under normobaric and hyperbaric conditions in 15 patients with prosthetic heart valves
Clinical details MES counts
Patient No. (age [y], sex) Valve type Valve position 1 bar 2.5 bar 1.75 bar 1 bar
1 (64, M) CM AVR 14 23 17 10
2 (75, M) CM A+MVR 31 107 63 32
3 (53, M) SJM MVR 148 302 240 187
4 (25, F) CM MVR 20 27 17 10
5 (39, M) CM AVR 21 150 110 47
6 (38, F) CM MVR 315 654 435 260
7 (50, M) CM AVR 13 49 11 0
8 (53, M) CM AVR 3 4 8 5
9 (53, M) SJM AVR 24 133 57 18
10 (50, M) CM AVR 5 44 22 4
11 (62, M) CM A+MVR 46 169 132 46
12 (41, M) SJM AVR 20 63 37 16
13 (58, M) CM AVR 18 32 28 12
14 (52, M) CM AVR 1 4 7 3
15 (61, M) SJM MVR 7 4 7 3
CM, Carbomedics; SJM, St Jude Medical; AVR, aortic valve replacement; MVR, mitral valve replacement; A+MVR, dual (aortic and mitral) valve replacement.
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embolic material. Although simultaneous insonation with 2
carrier frequencies, as reported by Brucher and Russell,36
appears promising, this approach remains to be evaluated.
Such distinction would be of particular interest, because it
appears possible that the counts of formed MES in pros-
thetic valve carriers could serve as a surrogate marker con-
cerning individual stroke risk or efficacy of oral
anticoagulation. Previous studies examining the clinical sig-
nificance of MES were potentially flawed through the high
counts of MES caused by gaseous emboli and thus unable to
provide valid results.
The interobserver agreement in this study was higher
than in previously reported ones, partially due to the fact
that both observers were trained in the same laboratory.
Additionally, MES in patients with prosthetic heart valves
have a higher intensity than those detected in patients with
native embolic sources37 and are thus easier to distinguish.
In conclusion, the present study provides further evi-
dence for gaseous bubbles as underlying embolic material
of part of the detected MES in patients with prosthetic heart
valves. The portion of MES caused by formed embolic
material remains to be evaluated.
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